Department of Psychiatry and Behavioral Sciences Archive — Page 4 of 12

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
April 21, 2022

Taylor, Newhouse, Petrie honored by geriatric psychiatry association

Vanderbilt’s Warren Taylor, MD, MHSc, Paul Newhouse, MD, and William Petrie, MD, were recently honored at the 2022 American Association for Geriatric Psychiatry (AAGP) Awards.

Portrait of Keith Meador, MD, wearing glasses, a dark suit, patterned shirt, and burgundy tie against a dark background.
April 13, 2022

Study compares moral injury in health care workers and veterans

A study comparing 618 military veterans who deployed to a combat zone after Sept. 11, 2001, and 2,099 health care workers (HCWs) working during the COVID-19 pandemic found similar levels of potential moral injury (PMI), with 46.1% of veterans and 50.7% of HCWs reporting PMI.

Black-and-white head-and-shoulders portrait of a mustached man in a suit and tie.
February 28, 2022

VUMC mourns loss of former Psychopharmacology director Ban

Thomas Arthur Ban, MD, emeritus professor of Psychiatry and former director of Vanderbilt’s Division of Psychopharmacology, died Feb. 4. He was 92.

Multiple blue-toned sagittal MRI scans of the human brain arranged together, with white technical labels overlaid.
January 27, 2022

White matter and psychosis

The microstructure of white matter in the brain could be an important risk marker for psychosis, Vanderbilt researchers have discovered.

Stylized microscopic illustration of a large irregular orange-and-black cell-like form surrounded by red blood cells in a bloodstream.
December 2, 2021

Study links depression scores, white blood cell count

Stylized side-profile illustration of a human head with the skull rendered translucent to reveal a network resembling brain blood vessels, dissolving into particles against a peach background.
September 30, 2021

Project seeks to treat Alzheimer’s in people with Down syndrome

A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS).